Literature DB >> 2564945

Replicative and cytopathic characteristics of HIV-2 and severity of infection.

J Albert, B Böttiger, G Biberfeld, E M Fenyö.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2564945     DOI： 10.1016/s0140-6736(89)92321-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Potent intratype neutralizing activity distinguishes human immunodeficiency virus type 2 (HIV-2) from HIV-1.

Authors:  Gülsen Ozkaya Sahin; Birgitta Holmgren; Zacarias da Silva; Jens Nielsen; Salma Nowroozalizadeh; Joakim Esbjörnsson; Fredrik Månsson; Sören Andersson; Hans Norrgren; Peter Aaby; Marianne Jansson; Eva Maria Fenyö
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

Review 2.  Guarding against the most dangerous emerging pathogens.

Authors:  P W Ewald
Journal:  Emerg Infect Dis       Date:  1996 Oct-Dec       Impact factor: 6.883

3.  Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage.

Authors:  A Mörner; A Björndal; J Albert; V N Kewalramani; D R Littman; R Inoue; R Thorstensson; E M Fenyö; E Björling
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

4.  Effect of complement on HIV-2 plasma antiviral activity is intratype specific and potent.

Authors:  Gülşen Özkaya Şahin; Birgitta Holmgren; Enas Sheik-Khalil; Zacarias da Silva; Jens Nielsen; Salma Nowroozalizadeh; Fredrik Månsson; Hans Norrgren; Peter Aaby; Eva Maria Fenyö; Marianne Jansson
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

5.  Cytopathic variants of an attenuated isolate of human immunodeficiency virus type 2 exhibit increased affinity for CD4.

Authors:  J A Hoxie; L F Brass; C H Pletcher; B S Haggarty; B H Hahn
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

6.  Biological and molecular variability of human immunodeficiency virus type 2 isolates from The Gambia.

Authors:  T F Schulz; D Whitby; J G Hoad; T Corrah; H Whittle; R A Weiss
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

7.  Frequent intratype neutralization by plasma immunoglobulin a identified in HIV type 2 infection.

Authors:  Gülşen Özkaya Şahin; Fredrik Månsson; Angelica A Palm; Elzbieta Vincic; Zacarias da Silva; Patrik Medstrand; Hans Norrgren; Eva Maria Fenyö; Marianne Jansson
Journal:  AIDS Res Hum Retroviruses       Date:  2012-11-21       Impact factor: 2.205
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.